[Cognitive disorders in Behçet's disease].

Autor:	Ovcharov PS; Nasonova Research Institute of Rheumatology, Moscow, Russia., Lisitsyna TA; Nasonova Research Institute of Rheumatology, Moscow, Russia., Veltishchev DY; Serbsky National Medical Research for Psychiatry and Narcology, Moscow Research Institute of Psychiatry, Moscow, Russia., Burenchev DV; Eramyshancev Moscow Clinical Hospital, Moscow Department of Health, Moscow, Russia., Ishchenko DA; Serbsky National Medical Research for Psychiatry and Narcology, Moscow Research Institute of Psychiatry, Moscow, Russia., Seravina OF; Serbsky National Medical Research for Psychiatry and Narcology, Moscow Research Institute of Psychiatry, Moscow, Russia., Kovalevskaya OB; Serbsky National Medical Research for Psychiatry and Narcology, Moscow Research Institute of Psychiatry, Moscow, Russia., Alekberova ZS; Nasonova Research Institute of Rheumatology, Moscow, Russia., Nasonov EL; Nasonova Research Institute of Rheumatology, Moscow, Russia.
Jazyk:	ruština
Zdroj:	Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova [Zh Nevrol Psikhiatr Im S S Korsakova] 2019; Vol. 119 (2), pp. 11-17.
DOI:	10.17116/jnevro201911902111
Abstrakt:	Aim: To study the prevalence of cognitive disorders (CD) and clinical/pathogenetic correlations of CD in patients with Behçet's Disease (BD). Material and Methods: One hundred and six BD patients were enrolled in the study. The majority of patients were natives of the North Caucasus (51.9%). Mean age was 33.3±0.98 years, mean illness duration 148.5±10.4 months. All the patients met the criteria of the International Study Group for BD (1990) classification. The disease activity was assessed by scoring system BDCAF. A diagnosis of a mental disorder (MD) was established by the psychiatrist in accordance with the ICD-10 using a semi-structured interview. The Montgomery-Asberg Depression Rating Scale (MADRS), the Hamilton Anxiety Rating Scale (HAM-A), a pathopsychological method 'Pictograms', clinical/psychological methods for assessment of cognitive functions (memory, attention concentration, logic thinking) were administered. Brain MRI was done in 44 (41.5%) BD patients. The study was conducted in the frames of the interdisciplinary program 'Stress factors and mental disorders in immune-mediated inflammatory rheumatic diseases'. Results: CD of mild to moderate severity were diagnosed in 82 (77.4%) and anxiety-depressive disorders in 81 (76.4%) of BD patients. The patients with CD were older compared to patients without cognitive disorders (34.3±1.07 vs 29.0±2.14, p=0.006). Patients with CD were most often (84.1% vs 50.0%, p=0.001) diagnosed with anxiety-depressive disorder (anxiety, chronic/recurrent depression). MADRS scores were higher (16.1±0.74 vs 12.2±1.06, p=0.005) though did not exceed the moderate level. The impact of chronic psychosocial stressors was detected more often in CD patients. MRI results showed that the frequency of chronic multifocal, predominantly subcortical, changes in the white matter was higher in CD patients. Conclusion: CD are characteristic of most patients with BD. They are associated with the age, anxiety-depressive disorders, chronic stressors and minor brain multifocal subcortical parenchymal MRI lesions.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu